Pheton (NASDAQ:PTHL) Trading Down 6.3% – Should You Sell?

Pheton Holdings Ltd (NASDAQ:PTHLGet Free Report)’s stock price dropped 6.3% on Wednesday . The company traded as low as $0.4208 and last traded at $0.4208. Approximately 67,936 shares changed hands during trading, a decline of 34% from the average daily volume of 103,207 shares. The stock had previously closed at $0.4491.

Analysts Set New Price Targets

A number of research analysts recently weighed in on PTHL shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Pheton in a report on Friday, October 31st. Wall Street Zen upgraded Pheton from a “sell” rating to a “hold” rating in a report on Sunday, September 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Pheton presently has a consensus rating of “Sell”.

Read Our Latest Stock Report on Pheton

Pheton Trading Down 6.3%

The business’s 50-day moving average is $0.56 and its two-hundred day moving average is $4.99.

About Pheton

(Get Free Report)

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

Further Reading

Receive News & Ratings for Pheton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pheton and related companies with MarketBeat.com's FREE daily email newsletter.